TRANSEPI
Live / Registered — Registered and renewed (as of 14 Feb 2025)
What this means for you
Registered since 21 Oct 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Oct 2024).
Record
- Serial number
- 85965343
- Registration number
- 4625776
- Mark type
- Stylized text
- Filed
- 20 Jun 2013
- Published for opposition
- 24 Dec 2013
- Registered
- 21 Oct 2014
- Next maintenance due
- 21 Oct 2024
- Attorney of record
- Keith R. Lange
Goods and services
- Class 005 — Pharmaceuticals: A proprietary dermatological delivery system, namely, drug delivery formulations sold as an integral ingredient of pharmaceutical preparations for the topical and transdermal delivery of a wide range of cosmetic ingredients, namely, micronutrients, antioxidants and sun-protecting ingredients
Owner
- Avidas Pharmaceuticals LLC, Doylestown, PA, US
- Avidas Pharmaceuticals LLC, Doylestown, PA, US
- Avidas Pharmaceuticals LLC, Doylestown, PA, US
Prosecution history
- 14 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Feb 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Feb 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Oct 2024 — TEAS SECTION 8 & 9 RECEIVED
- 21 Oct 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 Aug 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Aug 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Aug 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Apr 2021 — TEAS SECTION 8 & 15 RECEIVED
- 21 Oct 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Oct 2014 — REGISTERED-PRINCIPAL REGISTER
- 17 Sept 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Sept 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Sept 2014 — EXAMINER'S AMENDMENT ENTERED